Tech Company Financing Transactions
PhaseRx Funding Round
PhaseRx, based in Seattle, raised $1.5 million in funding from private investors.
Transaction Overview
Company Name
Announced On
12/26/2012
Transaction Type
Debt
Amount
$1,500,016
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
410 West Harrison St. 300
Seattle, WA 98119
USA
Seattle, WA 98119
USA
Phone
Website
Email Address
Overview
PhaseRx (NASDAQ: PZRX) is an RNAi delivery technology company developing a breakthrough polymer-based system that enables the systemic delivery of RNAi-based drugs and potentially other macromolecules as therapeutic products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Overell
VP - Bus. Development
Michael Houston
VP - Finance
Helen Tsui
Browse more venture capital transactions:
Prev: 12/22/2012: 2nd Watch venture capital transaction
Next: 12/26/2012: Aura Biosciences venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs